Latest reported quarter: Q4, ended Jun 2026
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $17.13B | $4.21B | $3.99B | $5.18B | $3.74B |
| Total Operating Revenue | $17.13B | $4.21B | $3.99B | $5.18B | $3.74B |
| Operating Expense | $13.63B | $3.13B | $3.14B | $4.59B | $2.77B |
| Selling and Admin Expenses | $2.37B | $637.00M | $546.00M | $595.00M | $589.00M |
| Depreciation & Amortization & Depletion | $410.00M | $111.00M | $101.00M | $100.00M | $98.00M |
| -Depreciation & Amortization | $410.00M | $111.00M | $101.00M | $100.00M | $98.00M |
| Other Operating Expenses | $10.85B | $2.38B | $2.49B | $3.90B | $2.08B |
| Operating Profit | $3.50B | $1.08B | $853.00M | $592.00M | $967.00M |
| Net Non-Operating Interest Income (Expense) | -$274.00M | -$60.00M | -$66.00M | -$98.00M | -$50.00M |
| Non-Operating Interest Income | $127.00M | $32.00M | $23.00M | $22.00M | $50.00M |
| Non-Operating Interest Expense | $401.00M | $92.00M | $89.00M | $120.00M | $100.00M |
| Other Income (Expense) | -$944.00M | -$103.00M | -$551.00M | -$172.00M | -$118.00M |
| Gain on Sale of Security | -$761.00M | $15.00M | -$496.00M | -$158.00M | -$122.00M |
| Earnings from Equity Interest | -$20.00M | -$2.00M | -$20.00M | $3.00M | -$1.00M |
| Special Income (Charges) | -$151.00M | -$113.00M | -$32.00M | -$14.00M | $8.00M |
| -Less:Restructuring and Mergern & Acquisition | $64.00M | $42.00M | $15.00M | $5.00M | $2.00M |
| -Less:Impairment of Capital Assets | $64.00M | – | – | – | – |
| -Less:Other Special Charges | $23.00M | $7.00M | $17.00M | $9.00M | -$10.00M |
| -Gain on Sale of Property/Plant/Equipment | $0.00 | – | – | – | – |
| Other Non-Operating Income (Expenses) | -$12.00M | -$3.00M | -$3.00M | -$3.00M | -$3.00M |
| Pretax Profit | $2.28B | $921.00M | $236.00M | $322.00M | $799.00M |
| Tax | $551.00M | $225.00M | $61.00M | $75.00M | $190.00M |
| Net Profit | $1.73B | $696.00M | $175.00M | $247.00M | $609.00M |
| Profit from Continuing Operations | $1.73B | $696.00M | $175.00M | $247.00M | $609.00M |
| Minority Interests | $42.00M | $5.00M | $9.00M | $18.00M | $10.00M |
| Net Income to Parent Company | $1.69B | $691.00M | $166.00M | $229.00M | $599.00M |
| Net Income to Common Stockholders | $1.69B | $691.00M | $166.00M | $229.00M | $599.00M |
| Basic EPS | $3.91 | $1.61 | $0.39 | $0.53 | $1.34 |
| Diluted EPS | $3.84 | $1.61 | $0.38 | $0.52 | $1.32 |
| Dividend Per Share | $0.56 | $0.00 | $0.28 | $0.00 | $0.28 |
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Total Assets | $22.48B | $22.48B | $21.78B | $21.47B | $22.77B |
| Total Current Assets | $8.45B | $8.45B | $7.54B | $6.73B | $7.97B |
| Cash and Cash Equivalents & Short-Term Investments | $4.21B | $4.21B | $3.60B | $2.02B | $4.37B |
| -Cash and Cash Equivalents | $4.21B | $4.21B | $3.60B | $2.02B | $4.37B |
| Receivables | $3.46B | $3.46B | $2.95B | $3.56B | $2.81B |
| -Accounts Receivable | $3.46B | $3.46B | $2.95B | $3.56B | $2.81B |
| Inventory | $487.00M | $487.00M | $652.00M | $828.00M | $509.00M |
| Other Current Assets | $306.00M | $306.00M | $337.00M | $324.00M | $282.00M |
| Total Non-Current Assets | $14.03B | $14.03B | $14.25B | $14.75B | $14.80B |
| Net PPE | $2.69B | $2.69B | $2.68B | $2.58B | $2.51B |
| -Gross PPE | $5.24B | $5.24B | $2.68B | $2.58B | $2.51B |
| -Accumulated Depreciation | -$2.55B | -$2.55B | – | – | – |
| Investments and Advances | $965.00M | $965.00M | $979.00M | $1.49B | $1.64B |
| Goodwill and Other Intangible Assets | $6.52B | $6.52B | $6.59B | $6.59B | $6.60B |
| -Goodwill | $3.65B | $3.65B | $3.65B | $3.64B | $3.64B |
| -Other Intangible Assets | $2.87B | $2.87B | $2.94B | $2.95B | $2.96B |
| Non-Current Deferred Assets | $2.44B | $2.44B | $2.60B | $2.62B | $2.63B |
| Other Non-Current Assets | $1.41B | $1.41B | $1.40B | $1.47B | $1.43B |
| Total Liabilities | $10.67B | $10.67B | $10.62B | $10.35B | $10.37B |
| Total Current Liabilities | $2.67B | $2.67B | $2.60B | $2.42B | $2.46B |
| Payables | $801.00M | $801.00M | $1.07B | $752.00M | $768.00M |
| -Other Payable | $801.00M | $801.00M | $1.07B | $752.00M | $768.00M |
| Current Accrued Expenses | $1.20B | $1.20B | $991.00M | $1.01B | $916.00M |
| Short-Term Debt and Capital Lease Obligation | $45.00M | $45.00M | $45.00M | $42.00M | $41.00M |
| -Current Capital Lease Obligation | $45.00M | $45.00M | $45.00M | $42.00M | $41.00M |
| Current Deferred Liabilities | $272.00M | $272.00M | $268.00M | $318.00M | $378.00M |
| Other Current Liabilities | $345.00M | $345.00M | $233.00M | $291.00M | $358.00M |
| Total Non-Current Liabilities | $8.00B | $8.00B | $8.02B | $7.93B | $7.91B |
| Long Term Debt and Capital Lease Obligation | $7.52B | $7.52B | $7.53B | $7.45B | $7.41B |
| -Long Term Debt | $6.61B | $6.61B | $6.61B | $6.60B | $6.60B |
| -Long Term Capital Lease Obligation | $917.00M | $917.00M | $924.00M | $849.00M | $808.00M |
| Employee Benefits | $263.00M | $263.00M | $264.00M | $264.00M | $278.00M |
| Other Non-Current Liabilities | $215.00M | $215.00M | $227.00M | $216.00M | $224.00M |
| Total Equity | $11.81B | $11.81B | $11.16B | $11.12B | $12.39B |
| Stockholders' Equity | $11.63B | $11.63B | $10.97B | $10.93B | $12.21B |
| Capital Stock | $4.00M | $4.00M | $4.00M | $4.00M | $4.00M |
| -Common Stock | $4.00M | $4.00M | $4.00M | $4.00M | $4.00M |
| Additional Paid-In Capital | $7.27B | $7.27B | $7.25B | $7.26B | $7.56B |
| Retained Earnings | $4.46B | $4.46B | $3.84B | $3.78B | $4.77B |
| Gains/Losses Not Affecting Retained Earnings | -$107.00M | -$107.00M | -$124.00M | -$123.00M | -$124.00M |
| Minority Interests | $186.00M | $186.00M | $191.00M | $194.00M | $184.00M |
| Line item | 2026 ANNUAL | 2026 Q4 | 2026 Q3 | 2026 Q2 | 2026 Q1 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.97B | $867.00M | $1.90B | -$669.00M | -$130.00M |
| Net cash flow from continuing operations | $1.97B | $867.00M | $1.90B | -$669.00M | -$130.00M |
| Net Income from Continuing Operations | $1.73B | $696.00M | $175.00M | $247.00M | $609.00M |
| Gain/Loss from Continuing Operations | $20.00M | $2.00M | $20.00M | -$3.00M | $1.00M |
| Depreciation & Depletion & Amortization | $410.00M | $111.00M | $101.00M | $100.00M | $98.00M |
| Deferred Tax | $271.00M | $155.00M | $16.00M | $10.00M | $90.00M |
| Other Non-Cash Items | $924.00M | $101.00M | $531.00M | $175.00M | $117.00M |
| Change in Working Capital | -$1.55B | -$272.00M | $1.03B | -$1.23B | -$1.07B |
| -Change in Receivables | -$1.06B | -$509.00M | $627.00M | -$736.00M | -$437.00M |
| -Change in Inventory | -$493.00M | -$106.00M | $550.00M | -$412.00M | -$525.00M |
| -Change in Payables and Accrued Expense | $66.00M | $292.00M | -$134.00M | $40.00M | -$132.00M |
| -Change In Other Working Capital | -$64.00M | $51.00M | -$14.00M | -$122.00M | $21.00M |
| Net cash flow from investing | -$705.00M | -$162.00M | -$150.00M | -$138.00M | -$255.00M |
| Net Cash Flow from Continuing Investing Activities | -$705.00M | -$162.00M | -$150.00M | -$138.00M | -$255.00M |
| Net PPE Purchase and Sale | -$502.00M | -$141.00M | -$135.00M | -$122.00M | -$104.00M |
| Net Business Purchase and Sale | -$8.00M | $0.00 | – | – | – |
| Net Investment Purchase and Sale | -$178.00M | -$10.00M | -$25.00M | -$8.00M | -$135.00M |
| Net Other Investing Changes | -$17.00M | -$11.00M | $18.00M | -$8.00M | -$16.00M |
| Financing Cash Flow | -$2.41B | -$101.00M | -$168.00M | -$1.54B | -$598.00M |
| Net Cash Flow from Continuing Financing Activities | -$2.41B | -$101.00M | -$168.00M | -$1.54B | -$598.00M |
| Net Issuance Payments Of Debt | $0.00 | – | – | – | – |
| Net Common Stock Issuance | -$2.00B | -$100.00M | -$100.00M | -$1.55B | -$250.00M |
| Cash Dividends Paid | -$287.00M | -$12.00M | -$128.00M | -$9.00M | -$138.00M |
| Net Other Financing Charges | -$124.00M | $11.00M | $60.00M | $15.00M | -$210.00M |
| Ending Cash Balance | $4.21B | $4.21B | $3.60B | $2.02B | $4.37B |
| Net Change in Cash | -$1.15B | $604.00M | $1.58B | -$2.35B | -$983.00M |
| Beginning Cash Balance | $5.35B | $3.60B | $2.02B | $4.37B | $5.35B |
| Free Cash Flow | $1.47B | $726.00M | $1.77B | -$791.00M | -$234.00M |
No comments yet — be the first to weigh in on FOXA.